Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Eli Lilly · Phase 2 · Completed · Enrollment 367

NCT06603571

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
LY3841136 Dose 1n/rn/rn/rn/rn/r
LY3841136 Dose 2n/rn/rn/rn/rn/r
LY3841136 Dose 3n/rn/rn/rn/rn/r
LY3841136 Dose 1 + Tirzepatide Dose 1n/rn/rn/rn/rn/r
LY3841136 Dose 2 + Tirzepatide Dose 1n/rn/rn/rn/rn/r
LY3841136 Dose 2 + Tirzepatide Dose 2n/rn/rn/rn/rn/r
LY3841136 Dose 3 + Tirzepatide Dose 3n/rn/rn/rn/rn/r
Tirzepatide Dose 3n/rn/rn/rn/rn/r
LY3841136 Dose 2 + Tirzepatide Dose 3n/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.